Spark Therapeutic’s treatment for rare inherited blindness, if approved by the FDA, could be the first gene therapy medicine for a genetic disease in the United States.
The new policy will make anyone on Medicaid who is infected with hepatitis C eligible for treatment. An advisory panel recommended the change one year ago. It will be costly for the state.
CVS Pharmacy is redesigning its stores to promote a more holistic approach to health. Company sales are up but the stock is down. Is it a buying opportunity?
AstraZeneca, which has faced declining revenue from patent losses and generic competition, wins U.S. regulatory approval for its oncology drug for advanced bladder cancer
GlaxoSmithKline announced $139 investment for a manufacturing site in Rockville, Md., and reaffirmed plans to spend $245 million in Upper Providence Township.
The deal with Parion Sciences could reach up to $535 million to license the promising treatment.
Wills Eye hospital is testing an experimental, laser-activated drug that selectively targets ocular melanoma. If successful, it would be the first therapy to preserve vision.
The device stimulates a key nerve with electricity.
The company said automation was the cause. The union says blamed it on call centers in the Philippines. In any event, 200 are losing their jobs.
Penn scientists helped lead an international effort to find people born with genes that were knocked out, meaning they inherited a deficient copy from both mother and father. One of the mutations already is guiding the hunt for a drug against heart disease.
When skin cancer spreads to other organs, even the best drugs fail in half of all patients. In a new Penn study, authors pinpoint why they fail with a fast, simple blood test, allowing for rapid deployment of a second kind of treatment.
Simply mandating that physicians register with the state databases led to a nearly 10 percent reduction in prescriptions for the most potent painkillers, the researchers reported in the April issue of Health Affairs, using data collected from 2011 to 2014.
On the same day the stockbroker for then-Georgia Congressman Tom Price bought him up to $90,000 of stock in six pharmaceutical companies last year, Price...
Suicides involving opioids more than doubled in 15 years, according to a new study — far less of an increase than opioid deaths overall, but one...
St. Louis-based pharmacy benefit management firm Express Scripts Holding Co. is shutting down its 53,000 square-foot office at the Bucks County Technology...